Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price23.99 USD
Fair value22.95
Ethical score30.0/100
Our investment reviews on this name
2026-10-02Read Markup23.99+0.0% to today ✓
2026-09-17Read Distribution24.89-3.6% to today ✓
2026-07-02Read Markup17.97+33.5% to today ✓
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
WisdomTree, Inc. holds its Markup at $23.99. Consolidating, no directional conviction, held for 35 days.
As held on the ledger · 2026-09-24
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 35 days
Price at the screen
$23.99
Valuation
43.62 trailing · 18.08 forward price to earnings
Values screen
FAIL· score 30.0
Beta
1.20
The Workings
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: financial services
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Prohibited keyword in sector/industry: financial services
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
WisdomTree, does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
Fair value range in USD, drawn from the 2026-09-24 screen. The gold marker is the market price at the same screen. The price runs 4.3% above the base estimate.
Third-party analyst targets: 7 covering, consensus None. The average target sits +8% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-24 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
ETFs Grow Fast But Ethics Block the Door
Every saver chasing market returns funnels cash into exchange traded funds and WisdomTree sits among the sponsors collecting fees on equities, bonds and alternatives. Revenue has jumped 48 percent while the forward multiple sits at 15.6 times and return on equity reaches 14 percent, numbers that look respectable next to a share price almost exactly at our fair value.
We pass because the ethical screen flags financial services outright. No amount of growth or analyst buy ratings changes that line. This is exactly what the screen is for.
Asset managers live and die with market swings, fee pressure and regulatory shifts that can compress margins quickly even when profit margins today sit at 11 percent. The lack of a clear moat adds another layer of uncertainty.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
WT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-02Markup · changed$23.99-3.6%Entry 6
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it none, with a mean price target of $20.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 11.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it none, with a mean price target of $20.
2026-08-18Markup$22.39+24.6%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 24.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it none, with a mean price target of $20.
2026-07-18Markup$17.97+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it none, with a mean price target of $20.
2026-07-03Markup$17.97+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$17.97Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
